
Monday, October 26, 2020 9:00:23 PM
Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer Seasoned executive with deep experience developing precision medicines for genetically defined diseases, most recently as COO of Array Biopharma PR Newswire CAMBRIDGE, Mass., Oct. 26, 2020 CA...
Find out more COGT - Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer
@whytestocks

Liked By
Spread the love. Be the first to like this post!
Recent FLNT News
- Annual Report (10-k) • Edgar (US Regulatory) • 03/15/2023 08:34:56 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/15/2023 08:19:33 PM
- Fluent Announces Fourth Quarter and Full-Year 2022 Financial Results • GlobeNewswire Inc. • 03/15/2023 08:15:00 PM
- Fluent, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023 • GlobeNewswire Inc. • 02/27/2023 02:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/13/2023 10:19:40 PM
- Schedule 13g<br /> (sc 13g/a) • Edgar (US Regulatory) • 02/06/2023 07:52:51 PM
- Schedule 13g<br /> (sc 13g/a) • Edgar (US Regulatory) • 02/06/2023 07:13:03 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/27/2023 09:06:17 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 01/25/2023 07:42:27 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/23/2022 10:24:28 PM
- Barrington Keeps Their Buy Rating on Fluent (FLNT) • TipRanks • 11/16/2022 02:15:27 PM
- Fluent (FLNT) Receives a Buy from Barrington • TipRanks • 11/08/2022 02:25:15 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/07/2022 09:32:41 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/07/2022 09:16:25 PM
- Fluent Announces Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/07/2022 09:01:00 PM
- Fluent, Inc. to Announce Third Quarter Financial Results on November 7, 2022 • GlobeNewswire Inc. • 10/26/2022 12:30:00 PM
- Fluent, Inc. Data is Now Available in TransUnion's TruAudience® Data Marketplace to Enable Enhanced Targeting Capabilities • GlobeNewswire Inc. • 10/17/2022 12:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/12/2022 08:43:45 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/12/2022 08:41:34 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/12/2022 08:38:41 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/11/2022 12:31:19 PM
- Fluent, Inc. Appoints David A. Graff and Richard C. Pfenniger, Jr. to Board of Directors • GlobeNewswire Inc. • 10/11/2022 12:30:00 PM
- Fluent Launches Purpose to Empower Consumer Financial Decisions • GlobeNewswire Inc. • 10/05/2022 12:30:00 PM
- Fluent Ranks #1 for Data Quality and Accuracy in Q2 2022 Truthset Truthscore™ Index • GlobeNewswire Inc. • 09/13/2022 12:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/17/2022 12:21:40 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM